OrbiMed Advisors is part of a partnership interested in acquiring all of Kinnate Biopharma. Baker Brothers increased an investment in Madrigal Pharmaceuticals.
Kinnate Biopharma, Madrigal Pharma, and More Stocks See Action From Activist Investors
2023-11-24 10:00
OrbiMed Advisors is part of a partnership interested in acquiring all of Kinnate Biopharma. Baker Brothers increased an investment in Madrigal Pharmaceuticals.
You Might Like...
Dutch Watchdog Wants to Know How ChatGPT Handles Personal Data
Safire Group Awarded Additional U.S. Air Force Small Business Innovation Research (SBIR) Phase II Contract
Atmosic’s Extremely Low-Power SoC Approved for Google Android TV Remote Controls
China Poses ‘Alarming’ Threat to US Power Grid, Lawmakers Told
EU Climate Chief Timmermans Resigns in Bid to Be Dutch Prime Minister
EV Owners Have Lowest Satisfaction with Most Important Mobile App Features, J.D. Power Finds
OpenAI offers $100,000 grants for ideas on AI governance
Adtran launches new FSP 3000 OLS to unlock the coherent optical edge